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Abstract
Background: Nocturnal heart block often occurs in patients with obstructive sleep apnoea (OSA). It is more likely to
be undiagnosed in heart block patients who are ignorant of the symptoms of sleep disorder. Berlin Questionnaire (BQ)
is a highly reliable way to discover the risk factors of OSA, whereas the validity in sleep-related heart block patients is
uncertain. We performed an observational study to address these issues and confirmed the potential protective effect
of continuous positive airway pressure (CPAP).
Methods: Patients who were previously diagnosed with nocturnal heart block with R-R pauses exceeding 2 seconds
were retrospective screened from the ECG centre of Zhongshan hospital. These recruited participants completed Berlin
Questionnaire and underwent polysomnography synchronously with 24-hour Holter monitoring. A cross-sectional
analysis was performed to confirm the association between nocturnal arrhythmia and OSA, as well as to assess the
diagnostic accuracy of the BQ. Subsequently, subjects diagnosed with OSA (apnoea-hypopnoea index > 5) underwent
3 consecutive days of CPAP therapy. On the third day, patients repeated 24-hour Holter monitoring within the
institution of CPAP.
Results: The symptoms of disruptive snoring and hypersomnolence in 72 enrolled patients were more related to the
occurrence of nocturnal heart block (r = 0.306, 0.226, respectively, p = 0.015, 0.019) than syncope (r = 0.134, p = 0.282)
and palpitations (r = 0.106, p = 0.119), which were prominent trait of our study population. The sensitivity, specificity,
positive and negative predictive value of the BQ at a cut-off point of 5 of AHI for detecting OSA in heart block patients
was 81.0 %, 44.4 %, 91.07 % and 25 %. Nocturnal heart block does not appear to occur exclusively in severe sleep
apnoea. The frequent occurrence of arrhythmias in prominent oxygen desaturation supports the correlation between
them. CPAP therapy resulted in significant decrease in the average number of episodes of heart block, from 148.58 ±
379.44 to 16.07 ± 58.52 (p < 0.05), same to the change of the longest RR pausing time (from 4.38 ± 2.95 s to 0.57 ± 1.05 s,
p = 0.169) in 51 patients. The optimal therapy pressure to make the observed arrhythmia disappeared is 12 cm H2O.
Conclusion: Concerning high prevalence of OSA in heart block patients, BQ provided an economical and efficient
screening method for OSA. For better management, CPAP therapy is feasible to prevent heart blocks avoiding
unnecessary concomitant pacemaker implantation.
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Background
Obstructive sleep apnoea (OSA) is an underestimated
clinical problem and is widely accepted to be associated
with significantly raised cardiovascular morbidity and
mortality [1]. Nocturnal heart block often occurs in pa-
tients with OSA and is reportedly a consequence of the
autonomic effects of recurrent apnoea with subsequent
oxygen desaturation, cyclic fluctuations in sympathova-
gal balance and cardiac hemodynamic changes [2]. As a
result, OSA has been identified as a risk factor for al-
most all types of arrhythmias, ranging from asymptom-
atic sinus bradycardia to sudden death [3, 4]. An initial
study [5] reported that almost 18 % of OSA patients de-
veloped bradycardic arrhythmias, while Miller et al. [6]
observed that the prevalence of heart block in patients
with sleep apnoea was 9–13 %. Screening significant
rhythm disturbances assumes particular clinical signifi-
cance in view of the adverse outcomes [7].
Nearly 80 % of men and 93 % of women with
moderate-to-severe sleep apnoea remain undiagnosed
within the community [8]. It is more likely to be
unrecognized in heart block patients who are ignorant
of the symptoms of sleep disorder. The incidence of
OSA in patients with nocturnal atrioventricular block or
sinus arrest is less defined. Overnight polysomnography
(PSG) is the gold standard for OSA diagnosis, but is not
generally available and is expensive to perform, requiring
highly trained personnel, sophisticated equipment, and
an entire night to record data. Berlin Questionnaire
(BQ), a reliable method of determining the risk factors
of OSA based on symptoms of snoring and daytime
sleepiness along with the presence of hypertension or
obesity, has good sensitivity ranging from 73 % to 86 %,
with a variable specificity of 44 % in sleep laboratory [9]
and of 77 % in primary care sites [10]. Considering that
not all patients who are observed to have heart block
need to undergo PSG, this screening strategy to identify
heart block patients at risk of developing OSA should be
revalued for validity and feasibility.
It has long been speculated that the vast majority of
OSA-related arrhythmias can be reversed during effect-
ive continuous positive airway pressure (CPAP) therapy
[11, 12]. However, clinical studies on nocturnal heart
block patients are limited and conflicting. One rando-
mised controlled trial by Sonya Craig et al. [13] con-
firmed that there was no significant reduction in
frequencies of dysrhythmias comparing therapeutic
CPAP groups with the subtherapeutic control, in con-
trast to the results of another randomized controlled
study [14] that confirmed the alleviation of ventricular
ectopy by CPAP in patients with heart failure. Moreover,
one case report [15] demonstrated that despite atrial
pacing, occasional atrioventricular (AV) block still per-
sisted during patient’s follow-up. According to the study
of Fietze [16], the prevalence of sleep disorder breathing
(SDB) in cardiac pacemaker patients was similar to those
without pacemakers. Consequently, screening for sleep
apnoea would be necessary before and after a pace-
maker. Therefore, we conducted this study to find a sim-
pler method of identifying sleep apnoea in these patients
and to examine the effect of CPAP in patients with OSA
and heart block.
Methods
Patient selection and study design
Firstly, we performed a retrospective screening in
patients previously diagnosed with nocturnal bradyar-
rhythmias in Electrocardiogram Centre of Zhongshan
Hospital. As R-R intervals of sleep apnoea-associated
heart block often exceed 2 seconds in duration [11], pa-
tients whose electrocardiogram (ECG) exhibited R-R
pauses exceeding 2 seconds were evaluated for medical
history and symptoms. If patients complained of severe
palpitation or syncope, they were more likely to have
obvious cardiac pathology. These patients were routinely
advised to have comprehensive electrophysiological
studies to rule out potential life-threatening risks. Pa-
tients with a second- or third-degree atrioventricular
block type Mobitz II and sinus arrest of at least 2 seconds
in duration were included in the study. III° and II° AV
conduction block were defined as intermittent or persist-
ent loss of association between P waves and QRS com-
plexes on ECG. Other cardiac bradyarrhythmias were
recorded but deemed not to be significant included
asymptomatic sinus bradycardia and a sinoatrial block
of at least 2 seconds in duration, which were also
grouped together as heart block. The exclusion criteria
were: 1. chronic atrial fibrillation, atrial or ventricular
premature complexes, symptomatic sinus node dys-
function; 2. chronic heart failure, history of stroke,
obvious cardiac pathology identified by electrophysio-
logical studies; 3. use of known anti-arrhythmic
medication, such as calcium channel blockers digoxin,
β-blockers, or atropine; 4. neurological and psychiatric
disease; 5. complained of self-reported illness, pain, or
circadian sleep disturbances. Those who had other
treatment for heart block or received CPAP/bi-level
positive airway pressure (BiPAP) also did not meet our
inclusion criterion. After application of all the above,
we recruited patients that met our criteria to sleep la-
boratory monitoring for further clinical evaluation.
Then patients consented to undergo polysomnography
together with 24-hour Holter monitoring to establish
the presence of OSA and arrhythmia. Subjects diagnosed
with OSA (apnoea-hypopnoea index > 5) underwent 3
consecutive days of CPAP therapy. On the third day, pa-
tients repeated 24-hour Holter monitoring within the
institution of CPAP. Our observational study as a part of
Wu et al. Respiratory Research  (2016) 17:16 Page 2 of 11
Australian registered clinical trials was approved by
the Ethics Committee of the Fudan University, and ap-
propriate informed written consent was obtained from
the subjects.
Sleep questionnaire and clinical assessment
Subjects with demographic data (age, gender, height,
weight, and neck circumference), smoking and alcohol
intake history were sampled. Medical history and cardio-
vascular medication were taking from the recruited pa-
tients. Each patient completed surveys including the
Epworth Sleepiness Scale (ESS) and an adapted version
of the Berlin Questionnaire (BQ). Body mass index
(BMI) was calculated as the ratio between weight (kg)
and height squared (m2). Coronary artery diseases refer
to angina, previous myocardial infarction and previous
coronary artery intervention. Hypertension, diabetes
mellitus and hyperlipidemia are diagnosed according to
the new guidelines. The Epworth Sleepiness Scale is an
8-question scale, scored from 0 to 3, that measures ex-
cessive daytime sleepiness as a reflection of a subject’s
tendency to fall asleep during specific non-stimulating
situations. The BQ includes questions regarding daytime
sleepiness, snoring, and obesity/hypertension and is used
to stratify patients for risk of OSA. The content of the
BQ has been previously described in detail by Netzer
[10]. The only difference was that 25 kg/m2 was used to
define obesity instead of 30 kg/m2 for all of the included
patients were Chinese.
Polysomnography
The participants who agreed to complete an overnight
in-hospital polysomnographic procedure were recorded
with an Alice-4 18-channel polysomnograph (Alice-4
Respironics, Pittsburgh, Pennsylvania, USA) in our sleep
centre. This investigation included monitoring of the elec-
troencephalogram, electrooculogram, submental electro-
myogram, electrocardiogram, thoracic and abdominal
bands, oronasal airflow by a nasal pressure transducer and
an oronasal thermistor, and arterial oxygen saturation by
transcutaneous pulse oximetry and a body position elec-
trode. Sleep stages were scored according to the standard
criteria of the American Academy of Sleep Medicine. An
obstructive apnoea event was defined as the absence of
oronasal airflow for ≥ 10 seconds associated with contin-
ued or increased inspiratory effort. A central apnoea was
defined as the absence of oronasal airflow for ≥ 10 seconds
associated with an absent inspiratory effort. Mixed ap-
noeas were typified by an episode of no air movement
resulting from central, followed by obstructive mecha-
nisms. Hypopnoea was defined as a ≥ 50 % reduction in
oronasal airflow accompanied by oxygen desaturation
more than 4 %. The apnoea-hypopnoea index (AHI) was
calculated by dividing the number of apnoeas and
hypopnoea by the number of hours of sleep. Interpreters
were blinded to the Berlin Questionnaire scores and poly-
somnographic results, and scoring was performed separ-
ately. Patients with an AHI between 5 and 15 were
considered to have mild OSA, patients with an AHI
between 15 and 30 were considered to have moderate
OSA, and patients with an AHI greater than 30 were con-
sidered to have severe OSA. In addition to measures of
OSA severity, the mean and lowest percentages of oxygen
desaturation (taken from the initial diagnostic polysomno-
graphy records) were recorded. The oxygen saturation
nadir was recorded after all results had been manually
checked for technical artefacts.
Continuous positive airway pressure
According to the guideline of the Chinese Respiratory
Society [17], CPAP therapy is best applied for the popu-
lation diagnosed with modest to severe OSA or mild
OSA accompanying obvious adverse symptoms such as
cardiovascular diseases. Patients conformed to the indi-
cation were performed for consecutive 3 nights. Before
the CPAP titration, all patients were given a comprehen-
sive educational explanation of CPAP treatment, and
underwent mask fitting from a wide range of mask types
and spent 30 minutes acclimatizing to CPAP in a bed
during the daytime. CPAP titration was performed fol-
lowing overnight polysomnography using the Autoset
self-adjusting CPAP device (REMstar-auto; Respironics).
The effective CPAP pressure for each patient was set at
the minimum pressure needed to abolish snoring and
obstructive respiratory events. In patients for whom
significant leak persisted, and who expressed their non-
adherence to the given pressure, the pressure was
manually decreased in 1 cm H2O increments while
maintaining the AHI < 10/h and SaO2 ≥ 90 % [18]. Ac-
ceptable compliance was considered if the patient used
CPAP more than 4 h in the third night. Those with the
mask leak > 0.4 L/s were recognized as lack of compli-
ance. Compliance was measured the third night results
electronically using a SmartCard embedded in the CPAP
machine (EncorePro; Respironics).
24-hour Holter electrocardiography
Together with overnight polysomnography and the third
day on CPAP, 24-hour Holter electrocardiography was
performed using a digital recorder with 12 channels.
The polysomnography and 24-hour Holter electrocardi-
ography were time-synchronized. Electrocardiograph re-
cordings were automatically interpreted by a software
engine and subsequently manually reviewed by 2 re-
searchers. For uncertain classification of an arrhythmia,
a cardiologist was consulted.
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Statistical analysis
Categorical data are presented as absolute numbers and
percentages and continuous data as the mean ± standard
deviation. Differences between groups were compared
by one-way ANOVA or the Kruskal-Wallis test (for vari-
ables with a non-normal distribution). Correlations were
calculated by a Pearson correlation matrix analysis. Sim-
ple and multiple logistic regression analyses were per-
formed to identify the risk factors associated with OSA.
The association between AHI and heart block was
assessed by univariate and multivariate logistic regres-
sion analyses with the results reported as an odds ratio
(OR) per 1-Uincrease of logarithmically transformed
AHI and a 95 % confidence interval (CI). Covariates,
such as age, gender, body mass index, diabetes mellitus,
and hypertension, were entered into multivariate models
if they were significant in univariate models. Patients
with CPAP therapy were classified into two subgroups at
an AHI cut-off point of 10. Values of p < 0.05 were con-
sidered significant. Analyses were performed with SPSS
18.0 for Windows (SPSS, Inc., Chicago, Illinois).
Results
Characteristics of recruited subjects
From 2008 to 2015, 93 patients previously diagnosed
with nocturnal heart block fulfilled the criteria to be en-
rolled. Four patients missed their appointments and ten
refused to participate in the PSG examination. Of the 79
patients who signed consent forms, 7 were excluded be-
cause of inadequate data. Thus, standard polysomnogra-
phy subsequently performed on 72 mainland Chinese
patients together with Holter monitoring. Sinus arrest or
sinoatrial block was present in 40 patients, sinus brady-
cardia with complete atrioventricular block was observed
in 28 patients, and both sinus arrest or sinoatrial block
and sinus bradycardia with complete atrioventricular
block were observed in 4 patients. Of the 72 subjects, 2
subjects were diagnosed with central apnoea and the
others had obstructive sleep apnoea. Patients were fur-
ther categorized in predefined strata according to Berlin
Questionnaire. Based on standard overnight polysomno-
graphy of 72 recruited patients, 63 patients diagnosed
with AHI > 5 were potentially responsive to CPAP. Two
diagnosed with predominantly central sleep apnoea and
5 patients with declined consent were excluded from
CPAP therapy. According to the defined criteria of com-
pliance to CPAP, 3 patients dropped out. Two patients
lacked synchronous data of Holter ECG on the third
night. Therefore, 56 patients had been called for CPAP
titration and only 51 patients finally received CPAP ther-
apy for consecutive 3 nights and repeated the Holter
monitoring with the institution of CPAP on the third
night. A flowchart of heart block patients included in
the screening and managing program of sleep apnoea is
displayed in Fig. 1.
The demographics and clinical characteristics of 72
patients are illustrated in Table 1. The high risk OSA
group included 56 patients, while the remaining 16 pa-
tients were considered to be low risk OSA group accord-
ing to the BQ. We first investigated the relationship
among two groups in terms of age, gender, BMI, and
cardiovascular disorders. In general, high risk individuals
were older, more obese, and more likely to smoke com-
pared to subjects in the low risk group and also exhib-
ited a higher prevalence of co-morbidities, including
hypertension and diabetes mellitus. However, regarding
to the occurrence of hyperlipidemia and coronary artery
disease, there was no significant difference between the
two groups. Patients’ characteristics in cardiovascular
co-morbidities also reflected in their medication use. Ex-
cessive daytime sleepiness, defined as score > 10, was sig-
nificantly different between the high and low risk groups
(11.34 ± 6.19 vs. 7.07 ± 5.39, p < 0.001). In a logistic re-
gression model, after adjusting for other confounding
factors, BMI and hypertension were independent predic-
tors in heart block patients for the risks of OSA (OR =
1.4 and 4.8, respectively, p < 0.001), while gender and
ESS (OR = 0.46 and 1.1, respectively, p = 0.16) were not.
The arrhythmias occurring during sleep from the elec-
trocardiogram and synchronous PSG were also analyzed.
Although arrhythmias in the high risk group exhibited
more severe than those in the low risk group, with re-
gard to the number of episodes of heart block and the
longest RR interval time, the differences between them
did not reach statistical significance (p = 0.137 and
0.163). No significant interactions between the variables
of arrhythmia and cardiovascular risk factors (CAD or
hyperlipidemia) were observed (p = 0.375 and 0.228), but
the number of episodes of heart block was a mild pre-
dictor of OSA risk (OR = 1.685, p = 0.98). Patients usu-
ally develop heart block during sleep without diurnal
symptoms or signs such as lightheadedness or syncope,
on the contrary, these asymptomatic patients presented
with characteristics of snoring and daytime sleepiness,
with differences between groups that were mild to mod-
erate but statistically significant compared (p = 0.039).
The symptoms of disruptive snoring and hypersomno-
lence were more related to the occurrence of heart block
(r = 0.306, 0.226, respectively, p = 0.015, 0.019) than
syncope (r = 0.134, p = 0.282) and palpitations (r = 0.106,
p = 0.119), which were prominent trait of our study
population.
Relationship between severity of OSA and heart block
To investigate the relationship between OSA and noc-
turnal heart block, we analysed these blocks during the
PSG recording. A Pearson correlation matrix analysis
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was performed in which sleep apnoea severity was sig-
nificantly related to neither the number of episodes of
bradyarrhythmia (r = 0.239, p = 0.273), nor the RR inter-
val time of second-degree atrioventricular block or sinus
arrest (r = 0.14, p = 0.524). In a second set of analyses
with substituted AHI of 30/h, the number of episodes of
heart block in patients with AHI ≥ 30/h was not signifi-
cantly higher than that observed in those with AHI < 30/
h (p = 0.636), but the RR interval time in patients with
AHI ≥ 30/h was significantly longer than that in those
with AHI < 30/h (p < 0.05). Heart block does not appear
to occur exclusively in severe sleep apnoea. Except that
20 % of the patients with an AHI of at least 60/h devel-
oped severe arrhythmias during sleep, seven patients
with an AHI below 15/h also developed severe arrhyth-
mias, four of which even had more than 40 episodes of
long RR intervals.
There is a clear tendency that heart block is more
likely to occur with greater O2 desaturation. On average,
heart block occurred with a mean O2 desaturation of
21 %. The inverse association between pronounced O2
saturation and prevalence of heart block was, however,
not so significantly evident in linear correlation analysis
for the night-time recordings (r = 0.199, p = 0.275).
Diagnostic accuracy of the Berlin Questionnaire in heart
block-associated OSA
Seventy-two patients were further divided into AHI of 5/
h, 15/h, and 30/h as cut-off point according to current
AASM guidelines, as shown in Table 2. The sensitivity,
specificity, and positive and negative predictive values of
the BQ in detecting OSA (AHI ≥ 5) were 81.0 %, 44.4 %,
91.07 % and 25 %, respectively. The positive and negative
likelihood ratios were 1.45 and 0.43. Considering an
AHI of 5/h, 15/h, and 30/h as the cut-off point, the over-
all diagnostic accuracy (a crude agreement rate) of the
BQ was 76 %, 78 %, and 47 %, respectively.
Comparisons of the parameters after the application of
CPAP therapy in 51 patients
The patients were evaluated by self-contrast method to
assess the efficacy of CPAP therapy as well as the sever-
ity of OSA and arrhythmias. 51 patients (47 men, 4
women) were performed for 3 consecutive nights of
CPAP treatment in our sleep centre. The mean age of
the 51 patients was 58.61 years old (ranged from 37 to
82). The mean AHI was 32.48/h (32.48 ± 20.90) at base-
line and 3.65/h (3.65 ± 2.63) on the third treatment night
with a mean O2 saturation significant improving from
Fig. 1 Flowchart of the heart block patients involved in screening and management program of sleep apnoea
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93.62 % ± 3.93 % to 96.32 % ± 1.23 %. The average epi-
sodes of heart block during sleep decreased significantly
(p < 0.05), from 148.58 ± 379.44 before therapy to 16.07
± 58.52 during CPAP, same to the change of the RR
interval time (from 4.38 ± 2.95 s to 0.57 ± 1.05 s, p =
0.169). CPAP therapy resulted in the abolition of noctur-
nal bradycardic arrhythmias in 41 patients (80 %). In the
six patients, the episodes of heart block on the third
Table 1 Baseline clinical characteristics according to Berlin questionnaire
Variable Low risk (n = 16) High risk (n = 56) p-value
Demographics
Age (yr) 48.20 ± 17.34 51.80 ± 13.54 0.185
Female, n (%) 7 (44 %) 4 (7 %) <0.001
BMI (kg/m2 ) 23.82 ± 3.36 28.78 ± 7.41 <0.001
Neck circumference (cm) 38.32 ± 2.77 42.20 ± 3.67 <0.001
Medical history
Smoking status, n (%) 3 (19 %) 38 (67 %) <0.001
Alcohol, n (%) 2 (12 %) 23 (41 %) <0.001
Hypertension, n (%) 3 (18 %) 29 (53 %) <0.001
Diabetes mellitus, n (%) 2 (13 %) 12 (22 %) 0.025 (<0.05)
Coronary artery disease, n (%) 4 (25 %) 8 (14 %) 0.135
Hyperlipidemia, n (%) 7 (44 %) 25 (45 %) 0.897
Causes of deteriorated cardiac conduction
SA block or sinus arrest, n (%) 8 (50 %) 32 (57 %) 0.618
Complete AV block, n (%) 7 (44 %) 21 (38 %) 0.657
Combined forms of heart block, n (%) 1 (6 %) 3 (5 %) 0.893
Cardiovascular medication
Platelet aggregation inhibitors, n (%) 1 (6 %) 7 (13 %) 0.490
Diuretic therapy, n (%) 3 (19 %) 18 (32 %) 0.305
ACE inhibitors/ARBs, n (%) 2 (12 %) 19 (34 %) 0.125
Statin therapy, n (%) 2 (12 %) 15 (27 %) 0.241
Symptoms
Syncope, n (%) 1 (6 %) 7 (13 %) 0.490
Palpitations, n (%) 2 (12 %) 12 (21 %) 0.433
Chest pain, n (%) 1 (6 %) 4 (7 %) 0.903
Snoring, n (%) 10 (63 %) 48 (86 %) 0.039 (<0.05)
Daytime sleepiness, n (%) 8 (50 %) 28 (57 %) 0.618
ESS score 7.07 ± 5.39 11.34 ± 6.19 <0.001
Baseline Holter ECG
RR interval (>2 s, events/h) 17.14 ± 26.30 196.06 ± 470.05 0.137
Longest RR (>2 s, second) 2.71 ± 0.86 3.56 ± 2.02 0.163
Baseline polysomnography
Obstructive and mixed apneas, n (%) 0 (0 %) 1 (2 %) 0.597
Obstructive apneas, n (%) 11 (69 %) 49 (88 %) 0.022 (<0.05)
Central apneas, n (%) 1 (6 %) 1 (2 %) 0.345
AHI (events/h) 12.94 ± 7.08 41.3 ± 17.85 <0.001
Mean SaO2 (%) 96.14 ± 0.89 91.76 ± 3.90 0.008 (<0.01)
Oxygen saturation nadir (%) 89 ± 5 86 ± 16 0.133
BMI Body Mass Index, ESS Excessive daytime sleepiness score, SA block sinoatrial block, AV block atrioventricular block, SaO2 oxyhaemoglobin saturation, ACE
inhibitor angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker
Values are presented as mean ± standard deviation or n (%)
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treatment night decreased from 95 % to 73 %. Four pa-
tients showed no relevant alterations, one of them
even exhibited a 21 % increase in frequency of blocks
during CPAP.
When patients were subdivided into AHI (<10) and
AHI (≥10) subgroups, there were no significant changes
for the group AHI (<10) in O2 desaturation, AHI, and
arrhythmia parameters. In contrast, the AHI (≥10) group
demonstrated great improvement. Table 3 shows the
changes in sleep and arrhythmia variables at baseline
and after CPAP at a cut-off point of AHI of 10.
To further analyse the impact of therapy pressure on
the parameters of sleep and arrhythmia, we selected dif-
ferent levels of CPAP pressure (5, 8, 10, 12, and 14 cm
H2O) in mild-severe sleep apnoea group (AHI > 10) and
collected corresponding changes of clinical outcomes.
The pressure curve (shown as Fig. 2) illustrates a dose-
associated improvement in O2 desaturation, AHI and
elimination of arrhythmia with CPAP therapy in the
setting of mild/severe sleep apnoea. The improvement of
AHI and O2 saturation with CPAP was immediate and
evident, even at low levels of CPAP, whereas with an
increasing continuous positive airway pressure, the
abolishment of arrhythmia events decreased after peak-
ing at 12 cm H2O.
Discussion
The present study observed that respiratory sleep disor-
ders are common among nocturnal heart block patients,
especially in patients with high risk factors associated
with OSA, such as obesity, habitual snoring or hyperten-
sion. To the best of our knowledge, this is the first re-
port of Berlin Questionnaire being administered to
nocturnal heart block patients. The principal findings in-
clude that BQ is an effective instrument for the recogni-
tion of sleep apnoea in heart block patients and this
kind of heart block, which occurs frequently during
sleep rather than wakefulness in OSA patients, can be
largely abolished following the institution of CPAP ther-
apy. OSA appears to be a trigger for heart block during
sleep, which may be a potential mechanism for noctur-
nal bradyarrhythmia.
Previous reports have examined the association be-
tween OSA and cardiac arrhythmias in selected group
with different severities of OSA or in different popula-
tions, such as frequent ventricular premature complexes,
Table 2 Diagnostic accuracy of Berlin questionnaire in detecting OSA in patients with heart block
A) Distributions of the two risk
groups with respect to AHI
Polysomnographic data High-risk group (n = 56) Low-risk group (n = 16)
AHI < 5 5 4
5≤ AHI < 15 17 8
15 ≤ AHI < 30 14 2
AHI≥ 30 20 2
B) Ability of risk grouping with elevated AHI
Polysomnographic data Sensitivity of BQ Specificity of BQ PPV NPV accuracy + LR - LR
AHI≥ 5 81.00 % 44.40 % 91.07 % 25.00 % 76.39 % 1.45 0.43
AHI≥ 15 89.47 % 35.29 % 60.71 % 75.00 % 77.78 % 1.39 0.30
AHI≥ 30 91.00 % 28.00 % 35.71 % 87.50 % 47.22 % 1.26 0.32
AHI apnea-hypopnea index, BQ Berlin questionnaire, PPV Positive Predictive Value, NPV Negative Predictive Value, LR Likelihood Ratio
Table 3 Sleep and arrhythmia parameters in subgroups prior to and following the application of CPAP therapy
Variable AHI < 10 (n = 10) AHI≥ 10 (n = 41) p-value*
Pressure (cm H2O) 8.07 ± 0.15 8.29 ± 3.50 0.647
Compliance (h/night) 4.7 ± 2.5 5.8 ± 3.1 0.307
Pre-CPAP Post-CPAP p-value** Pre-CPAP Post-CPAP p-value**
Mean O2 desaturation (%) 8 % 7 % 0.506 23 % 7 % 0.047
AHI (events/h) 5.28 ± 1.25 3.53 ± 0.35 0.189 41.01 ± 24.20 3.93 ± 2.58 0.014
RR interval(>2 s, events/h) 30.67 ± 38.66 35.33 ± 48.34 0.051 110.89 ± 299.27 16.07 ± 58.52 0.001
Longest RR (>2 s, second) 2.68 ± 1.12 2.6 ± 0.58 0.952 13.81 ± 50.29 0.53 ± 1.00 0.058
Values are given as mean ± SD and n %
*Comparison of CPAP parameters between two subgroups at an AHI cut-off point of 10
**Comparison of changes in the sleep and arrhythmia variables at baseline and after CPAP in two subgroups
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conduction delay arrhythmias [3], supraventricular ar-
rhythmias and atrial fibrillation [19]. They also suggested
that the incidence of cardiac conduction disorders was
more frequent in OSA patients than in the general
population [5, 6]. Moreover, cardiac arrhythmias have
been documented in up to 48 % of patients suffering
from OSA [20]. However, this literature is sparse and
conflicting on heart block. A population based study
[21] did not observe differences in the occurrence of
nocturnal cardiac break among the OSA and matched
control groups. Additionally, Harbison et al. [22] only
observed 7 cases of nocturnal cardiac break in 45 OSA
patients. Compared with other arrhythmias, the Sleep
Heart Health Study reported sinus pause was not com-
mon in patients with OSA [20]. Little information is
available regarding arrhythmia in Asian patients with
OSA up to now. In our study all the patients included
were mainland Chinese. We performed PSG on them
and calculated the occurrence of sleep apnoea as high as
87.5 %, complementing the early epidemiological studies
in which a high rate of cardiac arrhythmia patients iden-
tified from the general population developed OSA in
Asian population. Data from the epidemiological stud-
ies in China have estimated that the prevalence of
OSA in general population is approximately 3.62–
4.81 % [23, 24]. In particular, these characteristics of
obesity, disruptive snoring and hypersomnolence were
more related to the occurrence of heart block than
syncope and palpitations suggested the target popula-
tion that we emphasized. As a result, the defined
population was largely suspected of sleep disorder,
which explaining the higher occurrence of OSA. It is
notable that those patients conscious of their snoring
and sleepiness were more willing to be enrolled in our
study. The evaluation and selection from both physi-
cians and patients probably bias the occurrence of
OSA in all the arrhythmias but reflect the results in
this small kind of arrhythmias. Meanwhile, the high
occurrence of OSA, confirmed by PSG, indicates why
our study population was most responsive to CPAP.
Regarding the high prevalence of OSA and its poten-
tial prognostic implications in nocturnal heart block
patients, a combination of clinical symptoms and catego-
rized questionnaires helped to predict its occurrence.
The BQ, used as a screening tool, requires a high sensi-
tivity with an acceptable specificity. After systematically
performing and examining its validity, the BQ achieved
the highest sensitivity at a cut-off point ≥ 30/h for pre-
dicting AHI, which is similar to the latest finding of
Ulalsi et al. [9]. The performance of BQ in cardiovascu-
lar patients has been highly efficient and has a sensitivity
of 0.86 and specificity of 0.89 compared with sleep stud-
ies [25]. Such results with BQ were also achieved in
patients with atrial fibrillation [26] and resistant hyper-
tension [27]. However, the screening instrument in our
study was limited by a lack of specificity, as an elevated
value may result from snoring. This issue is currently of
interest because prior studies showed the occurrence of
an atrioventricular block was more likely induced by ob-
served apnoea and nocturnal hypoxemia, independent of
snoring. Therefore, without sleep apnoea or hypoxemia,
sole snoring hardly affects arrhythmia [28, 29]. This
could be a possible reason why the BQ is not a reliable
discriminating tool to rule out the non-OSA group.
Although BQ is a poor predictor of OSA with a speci-
ficity of 0.44, which is valid also for other references
[30], that does not mean the Berlin Questionnaire is
not recommended as an appropriate instrument to
identify patients with sleep apnoea. Given the high
cost of sleep monitoring and the lack of dedicated
sleep centres, this screening should be considered in
the evaluation of arrhythmias with possible risk factors
of OSA for its accuracy.
The number of episodes of bradycardia and sinus
pauses increased in parallel to the severity of OSA as re-
ported by Roche et al. [31]. Nevertheless, we did not find
severity of sleep apnoea assessed by AHI significantly re-
lated to bradyarrhythmia, contrary to those who sug-
gested a graded risk for arrhythmias depending on OSA
severity [6]. In light of these contradictory results, we
must take the large inter-individual variability in the epi-
sodes of heart block into account. As an observational
study, any confounding risks by unmeasured variables
cannot be excluded, even though we had excluded pa-
tients with most pre-existing cardiac disease to avoid
bias. Our observational study based on nocturnal heart
block patients, and was constructed to be neither a fully
Fig. 2 Percentages of improvement in the sleep and arrhythmia
parameters at different levels of CPAP therapy pressure. The curve
illustrates a dose-associated improvement in O2 desaturation, AHI
and elimination of arrhythmia at different levels of CPAP therapy
pressure (5, 8, 10, 12, and 14 cm H2O) in the setting of mild/severe
sleep apnoea (AHI > 10). N = 5/group
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representative population-based epidemiological study,
nor a general arrhythmia-based epidemiological study.
Therefore, the sympathovagal predominance, atrial dila-
tation, impaired baroreflex [32] and hemodynamic fluc-
tuation may predispose subjects to develop arrhythmia.
Of note, the influence of O2 desaturation on the occur-
rence of heart block was obvious that supported the
correlation between them. Furthermore, through the
sub-group analysis at the cut-point of AHI of 30/h, RR
interval time in patients with AHI ≥ 30/h was signifi-
cantly higher than in those with AHI < 30/h as demon-
strated in our results, which is consistent with the main
conclusions of the previous study [33].
After analysing the features of the subgroup (AHI <
10), we observed that most of the arrhythmia patients
with a lack of symptoms were stratified as low risk
OSA group, with a minimal or mild residual AHI. It
has been hypothesized that a REM-sleep-related AV
block occurs independently of episodes of apnoea or
hypopnoea. Similar features have been documented in
several cases report [34, 35]. Most of them remained
irrelevant arrhythmia changes despite CPAP therapy,
consistently, the improvement of O2 saturation was
also not distinct. We concluded that CPAP was not
completely preventative in this subgroup, as opposed
to those with more severe OSA.
Koehler et al. [36] reported that the magnitude of
bradycardia appeared to be related to the severity of
hypoxaemia. Several previous studies convincingly dem-
onstrated that the administration of oxygen attenuated
the bradycardia [37]. However, a case reported by Ken-
ichi Maeno [38] indicated that OSA can provoke heart
block without oxygen desaturation. Our findings show
the frequent occurrence of nocturnal heart block in
prominent oxygen desaturation and provide further evi-
dence that hypoxia with cessation of airflow is a predis-
posing condition for these arrhythmias. The reversibility
of nocturnal arrhythmias by CPAP has been demon-
strated in most patients with OSA [39]. In general, the
present study shows a favourable outcome with CPAP
by abolishing 80 % of nocturnal heart block in 51 con-
secutive patients, similar to the Becker’s reversal
outcomes [40], and an elimination in 72 % of patients of
Wolfram’s study [12]. It is well acknowledged that
atrioventricular block is observed during both REM and
non-REM sleep, but it is hard to differentiate from a
REM-sleep–related AV block, because it is often caused
by an increased dominated surge of the parasympathetic
nervous system. One case report observed that CPAP
treatment did not abolish REM-sleep–related AV blocks in
patients with mild or no OSA [41], which further supports
our subgroup analysis results. Why CPAP could not result
in a complete disappearance of nocturnal arrhythmias in
several severe patients, irrespective of an obvious cardiac
pathology or lack of compliance, remains unknown. After
plotting the association of treatment pressure with out-
comes, we observed a dose-relative effect on the therapy re-
sults. Our study confirms the previous findings [42] in
which CPAP application revealed an absence of a sinus and
AV block in mild sleep apnoea, which was better explained
by pressure effects. Different from an optimal pressure of
15 cm H2O to make the observed arrhythmia disappeared
as recorded by Ki-Hwan Ji [15], our curve show a pressure
of 12 H2O cm generates the greatest benefit except for the
improvement in O2 saturation.
Those symptomatic heart block patients, with lethal
risk of long duration of RR pauses exceeding 3 seconds,
indeed present a classic indication for the pacemaker
implantation according to the current national and
international guidelines. In our study, patients whose
blocks occurred during nocturnal sleep or daytime nap
with risks of sleep apnoea seldom developed long lasting
duration of second-degree AV block or sinus block
exceeding 5 seconds. A detailed analysis of hourly sum-
mary of electrocardiogram result (shown as Additional
file 1) and PSG together with Holter recording in a pa-
tient (shown as Additional file 2) showed 4957 episodes
of heart block with RR interval exceeding 2 seconds dur-
ing sleep. It has to be noted that these blocks of about
2 seconds duration occurred toward the end of the
apnoea episodes, which were abolished largely by CPAP
later. This directly demonstrates a strong association
between OSA and heart block. A meta-analysis of ten
randomized controlled trials has shown that atrial over-
drive pacing (AOP) is inferior to CPAP for treating
OSA-related heart block and there is a possibility that
CPAP therapy may reduce the need for cardiac pace-
makers, if patients are screened and treated early. How-
ever, the role of AOP in OSA by another meta-analysis
was not confirmed [43]. It was reported that SDB was
identified in 59 % of those bradyarrhythmia patients im-
planted with pacemakers [44]. Furthermore, Simantirakis
EN et al. [45] indicated AOP was inferior to CPAP on
reducing OSA severity. Based on this evidence, those
patients with heart block occurring exclusively during
obstructive sleep apnoea without obvious pathological
abnormality are the best target population for CPAP
therapy. Regarding the controversial indication of
pacemaker implantation, we emphasize the short wait-
ing time for diagnosis and treatment in our study,
since all patients had baseline and follow-up studies
just completed within 3 nights. Most often, in clinical
practice, after comprehensive evaluation of the med-
ical history, electrophysiological abnormalities and
other cardiac symptoms, pacemaker implantation is
considered and performed according to the patient’s
wish, or based on the recommendation of his or her
attending physician.
Wu et al. Respiratory Research  (2016) 17:16 Page 9 of 11
There should be a low threshold method such as BQ
for the identification of OSA that is mandatory to
prevent being misdiagnosed by cardiologist or neglected
by respiratory physician. Most importantly, this non-
pharmacological approach spares patients with concomi-
tant pacemaker therapy. Since patients with long-term
pacemaker still exhibit a high prevalence of OSA [44],
suggestion of screening OSA is an urgent option that
should draw the highest attention of cardiologists.
Several limitations of the present study should be
noted. Firstly, lack of electrophysiologic evaluation for
underlying disease may obscure the study population.
Secondly, it is difficult to match important determinants
for arrhythmia patients in a case-control design, owing
to inadequate numbers of patient.
Conclusion
Considering the high prevalence of OSA in heart block
patients, a systematic PSG should be ideally offered to
patients suffering from nocturnal heart block. Our
study complements the previous results that patients
with nocturnal cardiac arrhythmia have an increased
vulnerability to OSA, and provides a method for sys-
tematic OSA detection via BQ screening. For better
management in the sleep laboratory, it is feasible to
apply CPAP that abolishes the majority of apnoea and
apnoea-associated heart block.
Additional files
Additional file 1: Hourly summary of 24-hour Holter electrocardiog-
raphy showed nearly all these episodes of RR pauses occurred during
sleep. The most severe and frequent episodes of heart blocks appeared
at 03:00 am. (TIF 41502 kb)
Additional file 2: All the recurrent RR pauses in a patient during
sleep were not exceeding 3 seconds with longest RR duration
2.7 seconds on Holter monitoring. Arrows on PSG indicated obstructive
sleep apnoea characterized by cessation of nasal air flow and O2 desaturation
despite continuous thoracic and abdominal respiratory efforts. Occurrence of
heart block and sleep apnoea was time-synchronized highlighted by a circle
that suggested it was sleep apnoea-related heart block. SaO2 = oxygen
saturation; ECG = electrocardiogram. (TIF 247130 kb)
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